Strategic Meeting during this week between….

Strategic Meeting during this week between the Shareholders of Probiomed (Mexico) and AXXO in order to discuss our future strategy regarding the development and distribution of our Biotechnology Portfolio – with the focus especially on the Monoclonal Antibody Products. The fundament of our company is built on trust and on the experience of a dynamic, multi-disciplinary and highly qualified team. The application of a unified work methodology, with a focus on quality in everything we do. Thank you for such a great visit in Hamburg at the AXXO Headquarter.